NextCell Pharma (Sweden) Market Value
| NXTCL Stock | SEK 3.40 0.12 3.66% |
| Symbol | NextCell |
NextCell Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NextCell Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NextCell Pharma.
| 01/28/2025 |
| 02/27/2025 |
If you would invest 0.00 in NextCell Pharma on January 28, 2025 and sell it all today you would earn a total of 0.00 from holding NextCell Pharma AB or generate 0.0% return on investment in NextCell Pharma over 30 days. NextCell Pharma is related to or competes with Diamyd Medical, Mendus AB, Vicore Pharma, and Immunovia Publ. NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden More
NextCell Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NextCell Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NextCell Pharma AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.7 | |||
| Information Ratio | 0.1818 | |||
| Maximum Drawdown | 54.27 | |||
| Value At Risk | (6.92) | |||
| Potential Upside | 10.4 |
NextCell Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NextCell Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NextCell Pharma's standard deviation. In reality, there are many statistical measures that can use NextCell Pharma historical prices to predict the future NextCell Pharma's volatility.| Risk Adjusted Performance | 0.1431 | |||
| Jensen Alpha | 1.24 | |||
| Total Risk Alpha | 1.29 | |||
| Sortino Ratio | 0.2632 | |||
| Treynor Ratio | 1.32 |
NextCell Pharma AB Backtested Returns
NextCell Pharma is dangerous given 3 months investment horizon. NextCell Pharma AB has Sharpe Ratio of 0.19, which conveys that the firm had a 0.19 % return per unit of risk over the last 3 months. We are able to interpolate and collect twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.38% are justified by taking the suggested risk. Use NextCell Pharma AB Risk Adjusted Performance of 0.1431, downside deviation of 4.7, and Mean Deviation of 3.9 to evaluate company specific risk that cannot be diversified away. NextCell Pharma holds a performance score of 15 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.93, which conveys possible diversification benefits within a given portfolio. NextCell Pharma returns are very sensitive to returns on the market. As the market goes up or down, NextCell Pharma is expected to follow. Use NextCell Pharma AB semi variance, as well as the relationship between the daily balance of power and period momentum indicator , to analyze future returns on NextCell Pharma AB.
Auto-correlation | 0.28 |
Poor predictability
NextCell Pharma AB has poor predictability. Overlapping area represents the amount of predictability between NextCell Pharma time series from 28th of January 2025 to 12th of February 2025 and 12th of February 2025 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NextCell Pharma AB price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current NextCell Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
NextCell Pharma AB lagged returns against current returns
Autocorrelation, which is NextCell Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NextCell Pharma's stock expected returns. We can calculate the autocorrelation of NextCell Pharma returns to help us make a trade decision. For example, suppose you find that NextCell Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NextCell Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NextCell Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NextCell Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NextCell Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
NextCell Pharma Lagged Returns
When evaluating NextCell Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NextCell Pharma stock have on its future price. NextCell Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NextCell Pharma autocorrelation shows the relationship between NextCell Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in NextCell Pharma AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.